Biotech Stock Alert: Uplisting Could Send It Soaring

Dear Reader,

Last year, this company generated over $300 million in revenue—yet it still hasn't uplisted to a senior exchange!

The Form 10 has already been filed with NASDAQ, paving the way for the uplist.

With a price target more than 3x its current value as of Monday, March 31st, this could be a massive opportunity.

We're dropping this stock alert Tomorrow!

Sign up now and be ready—this stock may not stay at these levels for much longer!

(clicking any of the links above will automatically subscribe you to Huge Alerts. View privacy policy here)